Mark A. LaBarge

6.9k total citations · 1 hit paper
76 papers, 3.5k citations indexed

About

Mark A. LaBarge is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Mark A. LaBarge has authored 76 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 39 papers in Oncology and 19 papers in Cell Biology. Recurrent topics in Mark A. LaBarge's work include Cancer Cells and Metastasis (35 papers), Cellular Mechanics and Interactions (17 papers) and 3D Printing in Biomedical Research (14 papers). Mark A. LaBarge is often cited by papers focused on Cancer Cells and Metastasis (35 papers), Cellular Mechanics and Interactions (17 papers) and 3D Printing in Biomedical Research (14 papers). Mark A. LaBarge collaborates with scholars based in United States, Norway and Switzerland. Mark A. LaBarge's co-authors include Helen M. Blau, Mina J. Bissell, James C. Garbe, Martha R. Stampfer, René Villadsen, Agla J. Fridriksdottir, Ole W. Petersen, Zev J. Gartner, Michael E. Todhunter and Régis Doyonnas and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Mark A. LaBarge

72 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biological Progression from Adult Bone Marrow to Mononucleate Muscle Stem Cell to Multinucleate Muscle Fiber in Response to Injury

2002 606 citations Mark A. LaBarge, Helen M. Blau Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. LaBarge United States	26	2.1k	1.3k	590	572	540	76	3.5k
Amit Vasanji United States	37	1.9k 0.9×	1.1k 0.9×	603 1.0×	349 0.6×	662 1.2×	78	4.7k
Uri Ben‐David Israel	25	3.1k 1.5×	831 0.7×	536 0.9×	516 0.9×	442 0.8×	47	4.5k
Claudia Lengerke Germany	33	2.6k 1.2×	959 0.8×	376 0.6×	253 0.4×	894 1.7×	131	4.6k
Mitsuyasu Kato Japan	41	3.6k 1.7×	1.0k 0.8×	261 0.4×	290 0.5×	398 0.7×	125	5.4k
Laurent David France	26	2.9k 1.4×	455 0.4×	429 0.7×	396 0.7×	295 0.5×	74	4.1k
R. Grant Rowe United States	26	2.2k 1.0×	908 0.7×	217 0.4×	314 0.5×	775 1.4×	49	3.9k
Tetsuro Watabe Japan	44	4.6k 2.2×	1.7k 1.4×	461 0.8×	453 0.8×	586 1.1×	108	6.9k
Christa Maes Belgium	25	1.8k 0.9×	628 0.5×	619 1.0×	437 0.8×	230 0.4×	43	3.7k
Joel A. Spencer United States	23	1.9k 0.9×	1.9k 1.5×	1.0k 1.8×	1.1k 1.9×	491 0.9×	42	5.4k
Cristina Lo Celso United Kingdom	32	2.1k 1.0×	816 0.7×	753 1.3×	379 0.7×	633 1.2×	72	4.8k

Countries citing papers authored by Mark A. LaBarge

Since Specialization

Citations

This map shows the geographic impact of Mark A. LaBarge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. LaBarge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. LaBarge more than expected).

Fields of papers citing papers by Mark A. LaBarge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. LaBarge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. LaBarge. The network helps show where Mark A. LaBarge may publish in the future.

Co-authorship network of co-authors of Mark A. LaBarge

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. LaBarge. A scholar is included among the top collaborators of Mark A. LaBarge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. LaBarge. Mark A. LaBarge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hinz, Stefan, et al.. (2024). Multi‐Zone Visco‐Node‐Pore Sensing: A Microfluidic Platform for Multi‐Frequency Viscoelastic Phenotyping of Single Cells. Advanced Science. 11(43). e2406013–e2406013. 2 indexed citations

Angarola, Brittany, Siddhartha Sharma, Neerja Katiyar, et al.. (2024). Comprehensive single-cell aging atlas of healthy mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and cancer. Nature Aging. 5(1). 122–143. 16 indexed citations

LaBarge, Mark A.. (2023). Media for culturing epithelial cells. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information).

Miyano, Masaru, Rosalyn W. Sayaman, Parijat Senapati, et al.. (2021). Breast-Specific Molecular Clocks Comprised ofELF5Expression and Promoter Methylation Identify Individuals Susceptible to Cancer Initiation. Cancer Prevention Research. 14(8). 779–794. 14 indexed citations

Jokela, Tiina & Mark A. LaBarge. (2020). Integration of Mechanical and ECM Microenvironment Signals in the Determination of Cancer Stem Cell States. Current Stem Cell Reports. 7(1). 39–47. 13 indexed citations

Sayaman, Rosalyn W., Denise M. Wolf, Christina Yau, et al.. (2020). Abstract P1-21-08: Application of machine learning to elucidate the biology predicting response in the I-SPY 2 neoadjuvant breast cancer trial. Cancer Research. 80(4_Supplement). P1–21. 1 indexed citations

Vatter, Fanny A. Pelissier, Denis Schapiro, Hang Chang, et al.. (2018). High-Dimensional Phenotyping Identifies Age-Emergent Cells in Human Mammary Epithelia. Cell Reports. 23(4). 1205–1219. 32 indexed citations

Jokela, Tiina, et al.. (2017). Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound. Cell Reports. 21(2). 533–545. 26 indexed citations

Cerchiari, Alec E., James C. Garbe, Michael E. Todhunter, et al.. (2015). A strategy for tissue self-organization that is robust to cellular heterogeneity and plasticity. Proceedings of the National Academy of Sciences. 112(7). 2287–2292. 95 indexed citations

10.

Lin, Chun‐Han, et al.. (2015). Microenvironment rigidity modulates responses to the HER2 receptor tyrosine kinase inhibitor lapatinib via YAP and TAZ transcription factors. Molecular Biology of the Cell. 26(22). 3946–3953. 124 indexed citations

11.

Todhunter, Michael E., Alex J. Hughes, Maxwell C. Coyle, et al.. (2015). Programmed synthesis of three-dimensional tissues. Nature Methods. 12(10). 975–981. 201 indexed citations

12.

Lee, Jonathan, James C. Garbe, Lukáš Vrba, et al.. (2015). Age and the means of bypassing stasis influence the intrinsic subtype of immortalized human mammary epithelial cells. Frontiers in Cell and Developmental Biology. 3. 13–13. 24 indexed citations

13.

Cerchiari, Alec E., James C. Garbe, Michael E. Todhunter, et al.. (2014). Formation of Spatially and Geometrically Controlled Three-Dimensional Tissues in Soft Gels by Sacrificial Micromolding. Tissue Engineering Part C Methods. 21(6). 541–547. 21 indexed citations

14.

Wang, Yunshan, Mingxin Wen, Yong-Won Kwon, et al.. (2013). CUL4A Induces Epithelial–Mesenchymal Transition and Promotes Cancer Metastasis by Regulating ZEB1 Expression. Cancer Research. 74(2). 520–531. 157 indexed citations

15.

Garbe, James C., François Pépin, Agla J. Fridriksdottir, et al.. (2012). Accumulation of Multipotent Progenitors with a Basal Differentiation Bias during Aging of Human Mammary Epithelia. Cancer Research. 72(14). 3687–3701. 80 indexed citations

16.

LaBarge, Mark A., et al.. (2008). Is CD133 a marker of metastatic colon cancer stem cells?. Journal of Clinical Investigation. 118(6). 2021–4. 3 indexed citations

17.

Palermo, Adam T., Mark A. LaBarge, Régis Doyonnas, Jason H. Pomerantz, & Helen M. Blau. (2005). Bone marrow contribution to skeletal muscle: A physiological response to stress. Developmental Biology. 279(2). 336–344. 110 indexed citations

18.

Bissell, Mina J. & Mark A. LaBarge. (2005). Context, tissue plasticity, and cancer. Cancer Cell. 7(1). 17–23. 363 indexed citations

19.

LaBarge, Mark A. & Helen M. Blau. (2002). Biological Progression from Adult Bone Marrow to Mononucleate Muscle Stem Cell to Multinucleate Muscle Fiber in Response to Injury. Cell. 111(4). 589–601. 606 indexed citations breakdown →

20.

Hitoshi, Yasumichi, James B. Lorens, Shinichi Kitada, et al.. (1998). Toso, a Cell Surface, Specific Regulator of Fas-Induced Apoptosis in T Cells. Immunity. 8(4). 461–471. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact